Drug Type Chemical drugs |
Synonyms Hosu 53 |
Mechanism CALR modulators(calreticulin modulators), CD38 inhibitors(Lymphocyte differentiation antigen CD38 inhibitors), CD47 inhibitors(Cluster of differentiation 47 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Adult Acute Myeloblastic Leukemia | Preclinical | US | 12 Dec 2022 | |
Adult Acute Myeloblastic Leukemia | Preclinical | US | 12 Dec 2022 |